Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Debt / NOTE 0.125%12/1
-
Market price (% of par)
-
92.51%
-
Total 13F principal
-
$517,348,516
-
Principal change
-
-$25,702,734
-
Total reported market value
-
$478,765,818
-
Number of holders
-
42
-
Value change
-
-$23,007,437
-
Number of buys
-
15
-
Number of sells
-
21
Institutional Holders of IONIS PHARMACEUTICALS INC - NOTE 0.125%12/1 as of Q1 2023
As of 31 Mar 2023,
IONIS PHARMACEUTICALS INC - NOTE 0.125%12/1 was held by
42 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$517,348,516
in principal (par value) of the bond.
The largest 10 bondholders included
TENOR CAPITAL MANAGEMENT Co., L.P., DeepCurrents Investment Group LLC, Opti Capital Management, LP, D. E. Shaw & Co., Inc., BRAIDWELL LP, AVIVA PLC, Sonora Investment Management Group, LLC, BlackRock Inc., DLD Asset Management, LP, and Thrivent Financial for Lutherans.
This page lists
42
institutional bondholders reporting positions
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.